{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T13:18:44Z","timestamp":1769087924539,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.vaccine.2025.127751","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T21:26:39Z","timestamp":1758057999000},"page":"127751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Longevity of immune-response provided by at least one dose of vi-DT vaccine 5\u00a0years after vaccination among healthy Filipino adults and children"],"prefix":"10.1016","volume":"64","author":[{"given":"Rejwana Haque","family":"Pial","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rosario","family":"Capeding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birkneh Tilahun","family":"Tadesse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"Excler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina Rok","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Lyeong","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Il-Yeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Seung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seongsu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagadeesh Reddy","family":"Eluru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Young","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue Kyoung","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Hwa","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Keun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Hoon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seon-Young","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deok Ryun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manki","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Anh","family":"Wartel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarun","family":"Saluja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushant","family":"Sahastrabuddhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2025.127751_bb0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1473-3099(18)30685-6","article-title":"The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017","volume":"19","author":"Stanaway","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127751_bb0010","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-2074-1","article-title":"Geographical distribution of typhoid risk factors in low and middle income countries","volume":"16","author":"Lee","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"27","key":"10.1016\/j.vaccine.2025.127751_bb0015","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1016\/j.vaccine.2017.05.001","article-title":"Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings","volume":"35","author":"Antill\u00f3n","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127751_bb0020","series-title":"The Lancet Infectious Diseases","first-page":"340","article-title":"The global burden of enteric fevers in the age of typhoid-conjugate vaccines","volume":"19","author":"Wierzba","year":"2019"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127751_bb0025","doi-asserted-by":"crossref","first-page":"e1005","DOI":"10.1016\/S2666-5247(23)00214-8","article-title":"Population structure of Salmonella enterica Typhi in Harare, Zimbabwe (2012\u201319) before typhoid conjugate vaccine roll-out: a genomic epidemiology study","volume":"4","author":"Thilliez","year":"2023","journal-title":"Lancet Microbe"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127751_bb0030","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ng.3281","article-title":"Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter-and intracontinental transmission events","volume":"47","author":"Wong","year":"2015","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127751_bb0035","doi-asserted-by":"crossref","DOI":"10.1186\/s12866-018-1332-3","article-title":"Multi-drug resistant Salmonella enterica serovar Typhi isolates with reduced susceptibility to ciprofloxacin in Kenya","volume":"18","author":"Mutai","year":"2018","journal-title":"BMC Microbiol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2025.127751_bb0040","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/ofid\/ofad135","article-title":"Typhoid Control in an Era of Antimicrobial Resistance: Challenges and Opportunities","volume":"10","author":"Vanderslott","year":"2023","journal-title":"Open Forum Infect Dis [Internet]"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127751_bb0045","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/cid\/ciy386","article-title":"Determining the best immunization strategy for protecting African children against invasive Salmonella disease","volume":"67","author":"Jeon","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127751_bb0050","series-title":"GAVI Alliance Board Meeting GAVI Alliance Board Meeting Final Minutes","year":"2025"},{"key":"10.1016\/j.vaccine.2025.127751_bb0055","series-title":"Clinical Infectious Diseases","first-page":"393","article-title":"Safety and Immunogenicity of a Vi Polysaccharide-Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) in Healthy Infants, Children, and Adults in Typhoid Endemic Areas: A Multicenter, 2-Cohort, Open-Label, Double-Blind, Randomized Controlled Phase 3 Study","volume":"61","author":"Mohan","year":"2015"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127751_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-022-00434-8","article-title":"Immune persistence and response to booster dose of Vi-DT vaccine at 27.5\u00a0months post-first dose","volume":"7","author":"Capeding","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2025.127751_bb0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1073\/pnas.1819612116","article-title":"Costantino P. On the mechanisms of conjugate vaccines. Proceedings of the National Academy of Sciences of the United States of America","volume":"116","author":"Rappuoli","year":"2019","journal-title":"National Academy of Sciences"},{"key":"10.1016\/j.vaccine.2025.127751_bb0070","series-title":"Typhoid conjugate vaccines: making vaccine history in Africa","first-page":"673","volume":"17","author":"Meiring","year":"2018"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127751_bb0075","article-title":"Typhoid conjugate vaccines for preventing typhoid fever (enteric fever)","volume":"2023","author":"Gloeck","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.vaccine.2025.127751_bb0080","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1473-3099(18)30804-1","article-title":"Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study","volume":"19","author":"Bilcke","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127751_bb0085","first-page":"27","article-title":"Safety and immunogenicity of Vi-DT conjugate vaccine among 6\u201323-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study","volume":"1","author":"Capeding","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127751_bb0090","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1473-3099(21)00455-2","article-title":"Safety and immunogenicity of the Vi-DT typhoid conjugate vaccine in healthy volunteers in Nepal: an observer-blind, active-controlled, randomized, non-inferiority, phase 3 trial","volume":"22","author":"Kumar Rai","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"26","key":"10.1016\/j.vaccine.2025.127751_bb0095","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1016\/j.vaccine.2018.05.038","article-title":"Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children","volume":"36","author":"Capeding","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127751_bb0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/ijmr.IJMR_1890_17","article-title":"The need & the issues related to new-generation typhoid conjugate vaccines in India","volume":"151","author":"Vashishtha","year":"2020","journal-title":"The Indian journal of medical research NLM (Medline)"},{"issue":"20","key":"10.1016\/j.vaccine.2025.127751_bb0105","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.vaccine.2014.02.050","article-title":"Re-examination of immune response and estimation of anti-Vi IgG protective threshold against typhoid fever-based on the efficacy trial of Vi conjugate in young children","volume":"32","author":"Szu","year":"2014","journal-title":"Vaccine"},{"issue":"10425","key":"10.1016\/j.vaccine.2025.127751_bb0110","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(23)02031-7","article-title":"Efficacy of typhoid conjugate vaccine: final analysis of a 4-year, phase 3, randomized controlled trial in Malawian children","volume":"403","author":"Patel","year":"2024","journal-title":"Lancet"},{"issue":"45","key":"10.1016\/j.vaccine.2025.127751_bb0115","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1016\/j.vaccine.2021.07.073","article-title":"Persisting antibody responses to Vi polysaccharide\u2013tetanus toxoid conjugate (Typbar TCV\u00ae) vaccine up to 7\u00a0years following primary vaccination of children\u00a0<\u00a02\u00a0years of age with, or without, a booster vaccination","volume":"39","author":"Vadrevu","year":"2021","journal-title":"Vaccine [Internet]"},{"issue":"10461","key":"10.1016\/j.vaccine.2025.127751_bb0120","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0140-6736(24)01494-6","article-title":"5-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in Bangladeshi children (TyVOID): a cluster randomized trial","volume":"404","author":"Qadri","year":"2024","journal-title":"Lancet [Internet]"},{"key":"10.1016\/j.vaccine.2025.127751_bb0125","series-title":"WHO position paper Typhoid vaccine","year":"2018"},{"issue":"71","key":"10.1016\/j.vaccine.2025.127751_bb0130","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1093\/cid\/ciaa504","article-title":"Review on the recent advances on typhoid vaccine development and challenges ahead","volume":"15","author":"Syed","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127751_bb0135","doi-asserted-by":"crossref","DOI":"10.1128\/cdli.4.2.156-167.1997","article-title":"Standardization and a Multilaboratory Comparison of Neisseria meningitidis Serogroup A and C Serum Bactericidal Assays","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2025.127751_bb0140","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/155.1.79","article-title":"B Subunit-Whole Cell and Whole Cell-Only Oral Vaccines Against Cholera: Studies on Reactogenicity and Immunogenicity [Internet]","volume":"155","author":"Clemens","year":"1987","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127751_bb0145","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.micpath.2016.05.013","article-title":"Serum bactericidal assay for the evaluation of typhoid vaccine using a semi-automated colony-counting method","volume":"97","author":"Jang","year":"2016","journal-title":"[Internet] Microb Pathog"},{"issue":"61","key":"10.1016\/j.vaccine.2025.127751_bb0150","doi-asserted-by":"crossref","first-page":"S266","DOI":"10.1093\/cid\/civ673","article-title":"Control of invasive salmonella disease in Africa: Is there a role for human challenge models?","volume":"1","author":"Gibani","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"71","key":"10.1016\/j.vaccine.2025.127751_bb0155","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1093\/cid\/ciaa343","article-title":"Typhoid conjugate vaccines and enteric fever control: Where to next?","volume":"15","author":"Duncan Steele","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127751_bb0160","series-title":"Mitigating the effects of climate change on human health with vaccines and vaccinations","volume":"11","author":"Kim","year":"2023"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25010485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25010485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:50:37Z","timestamp":1769025037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25010485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":32,"alternative-id":["S0264410X25010485"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127751","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longevity of immune-response provided by at least one dose of vi-DT vaccine 5\u00a0years after vaccination among healthy Filipino adults and children","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127751"}}